drug discovery

The future of flow cytometry: from semi-automated gating to unbiased analysis

Commercial flow cytometry methods have been used in basic research and clinical diagnostics labs since the 1970s, primarily for immunology and haematology applications, and, more recently, its benefits have been realised at various stages of pre-clinical and clinical drug discovery and development. It has become a critical technology, with a global market valued at USD […]

Automated vs manual gating in flow cytometry: potential game changer?

With a constant increase in demand for new drugs, pharmaceutical companies face pressure to continuously expand their research and development (R&D) efforts. Flow cytometry is a diverse and crucial technique in pharmaceutical research, used to investigate disease aetiology and alterations in immune responses, as well as for quantitative studies. Flow cytometry has the potential to […]

Article: Bridging the automation gap

As technology innovation progresses at a rapid pace, laboratory automation will continue to permeate a broad range of sectors, from genomics and proteomics to drug discovery and clinical diagnostics, for the foreseeable future. Our article with European Pharmaceutical Manufacturer, discusses how automation can benefit the pharma industry when it comes to data processing and analytics. […]